Suppliers / Dexcel Pharma

Dexcel Pharma

Germany 529 employees 2 duplicate records merged Updated 9 July 2026

Dexcel Pharma is a finished-dose manufacturer based in Germany. It appears in 92 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, MHRA (UK) and MPA (SE). Its GMP standing is certified by ZLG (DE), NAFDAC (NG) and EMA.

0
active US DMFs
0
valid CEPs
3
registered plants
92
filings across 8 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Bavaria, Germany Not on file
Alzenau, Germany Not on file
Southern Industrial Zone or Akiva, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 40 1
MHRA (UK) 31 None
MPA (SE) 8 None
US FDA 5 None
INFARMED (PT) 3 None
AIFA (IT) 3 None
ZLG (DE) None 4
NAFDAC (NG) None 2

Comparing suppliers?

Choose your molecules and target markets. Dexcel Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 17 active litigation matters are on record.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates